Clinical Management of Leiomyoma

This publication has 91 references indexed in Scilit:

• Gene Expression in Uterine Leiomyoma from Tumors Likely to Be Growing (from Black Women over 35) and Tumors Likely to Be Non-Growing (from White Women over 35)
  PLOS ONE, 2013
• The estimated annual cost of uterine leiomyomata in the United States
  American Journal of Obstetrics and Gynecology, 2012
• Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma
  Matrix Biology, 2012
• 1,25-Dihydroxyvitamin D3 Reduces TGF-β3-Induced Fibrosis-Related Gene Expression in Human Uterine Leiomyoma Cells
  The Journal of Clinical Endocrinology & Metabolism, 2011
• Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells
  Fertility and Sterility, 2010
• High Aromatase Expression in Uterine Leiomyoma Tissues of African-American Women
  The Journal of Clinical Endocrinology & Metabolism, 2009
• Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care
  American Journal of Obstetrics and Gynecology, 2009
• Growth of uterine leiomyomata among premenopausal black and white women
  Proceedings of the National Academy of Sciences, 2008
• CDB-2914 for Uterine Leiomyomata Treatment
  Obstetrics & Gynecology, 2008
• Midterm Clinical and First Reproductive Results of a Randomized Controlled Trial Comparing Uterine Fibroid Embolization and Myomectomy
  CardioVascular and Interventional Radiology, 2007